Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brunangelo Falini

Showing results (81-90 of 246) with videos related to

Pageof 25
Sort By:
Blood|July 10, 2009
Minimal residual disease levels assessed by NPM1 mutation-specific RQ-PCR provide important prognostic information in AMLSusanne Schnittger, Wolfgang Kern, Claudia Tschulik, et al.
Haematologica|September 8, 2009
The EML4-ALK transcript but not the fusion protein can be expressed in reactive and neoplastic lymphoid tissuesGabriella Sozzi, Maria Paola Martelli, Davide Conte, et al.
Pediatric Reports|November 5, 2011
Pathobiology of ALK-negative anaplastic large cell lymphomaStefano A Pileri, Claudio Agostinelli, Francesco Bacci, et al.
Tumori|May 2, 2019
Flower cells of tropical descent: a challenging case of adult T-cell leukemia/lymphomaGiovanni Martino, Magda Zanelli, Andrea Marra, et al.
The Journal of Molecular Diagnostics : JMD|April 29, 2006
Denaturing high-performance liquid chromatography: a valid approach for identifying NPM1 mutations in acute myeloid leukemiaGiovanni Roti, Roberto Rosati, Rossella Bonasso, et al.
Seminars in Diagnostic Pathology|August 17, 2011
Lymphoma classification: the quiet after the stormStefano A Pileri, Claudio Agostinelli, Elena Sabattini, et al.
Annals of the Rheumatic Diseases|August 21, 2012
IL-17-producing CD4-CD8- T cells are expanded in the peripheral blood, infiltrate salivary glands and are resistant to corticosteroids in patients with primary Sjogren's syndromeAlessia Alunno, Onelia Bistoni, Elena Bartoloni, et al.
Leukemia|January 10, 2019
IDH1-R132 changes vary according to NPM1 and other mutations status in AMLBrunangelo Falini, Orietta Spinelli, Manja Meggendorfer, et al.
Blood|August 4, 2005
Nucleophosmin gene mutations are predictors of favorable prognosis in acute myelogenous leukemia with a normal karyotypeSusanne Schnittger, Claudia Schoch, Wolfgang Kern, et al.
Haematologica|December 11, 2008
Cytoplasmic nucleophosmin is not detected in blastic plasmacytoid dendritic cell neoplasmFabio Facchetti, Stefano A Pileri, Claudio Agostinelli, et al.
Pageof 25

Showing results (81-90 of 246) with videos related to

Sort By:
Pageof 25
Blood|July 10, 2009
Minimal residual disease levels assessed by NPM1 mutation-specific RQ-PCR provide important prognostic information in AMLSusanne Schnittger, Wolfgang Kern, Claudia Tschulik, et al.
Haematologica|September 8, 2009
The EML4-ALK transcript but not the fusion protein can be expressed in reactive and neoplastic lymphoid tissuesGabriella Sozzi, Maria Paola Martelli, Davide Conte, et al.
Pediatric Reports|November 5, 2011
Pathobiology of ALK-negative anaplastic large cell lymphomaStefano A Pileri, Claudio Agostinelli, Francesco Bacci, et al.
Tumori|May 2, 2019
Flower cells of tropical descent: a challenging case of adult T-cell leukemia/lymphomaGiovanni Martino, Magda Zanelli, Andrea Marra, et al.
The Journal of Molecular Diagnostics : JMD|April 29, 2006
Denaturing high-performance liquid chromatography: a valid approach for identifying NPM1 mutations in acute myeloid leukemiaGiovanni Roti, Roberto Rosati, Rossella Bonasso, et al.
Seminars in Diagnostic Pathology|August 17, 2011
Lymphoma classification: the quiet after the stormStefano A Pileri, Claudio Agostinelli, Elena Sabattini, et al.
Annals of the Rheumatic Diseases|August 21, 2012
IL-17-producing CD4-CD8- T cells are expanded in the peripheral blood, infiltrate salivary glands and are resistant to corticosteroids in patients with primary Sjogren's syndromeAlessia Alunno, Onelia Bistoni, Elena Bartoloni, et al.
Leukemia|January 10, 2019
IDH1-R132 changes vary according to NPM1 and other mutations status in AMLBrunangelo Falini, Orietta Spinelli, Manja Meggendorfer, et al.
Blood|August 4, 2005
Nucleophosmin gene mutations are predictors of favorable prognosis in acute myelogenous leukemia with a normal karyotypeSusanne Schnittger, Claudia Schoch, Wolfgang Kern, et al.
Haematologica|December 11, 2008
Cytoplasmic nucleophosmin is not detected in blastic plasmacytoid dendritic cell neoplasmFabio Facchetti, Stefano A Pileri, Claudio Agostinelli, et al.
Pageof 25